Correspondence 0001104659-26-060215 from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: May 13, 2026 · CIK: 0001130598 · Accession: 0001104659-26-060215
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295727
Letter
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940 (267) 759-3680
May 13, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
Filed May 8, 2026
File No. 333-295727
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Traws Pharma, Inc., a Delaware corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-295727) to become effective on Friday, May 15, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very Truly Yours,
Traws Pharma, Inc.
Show Raw Text
CORRESP 1 filename1.htm Traws Pharma, Inc. 12 Penns Trail Newtown, PA 18940 (267) 759-3680 May 13, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Traws Pharma, Inc. Registration Statement on Form S-3 Filed May 8, 2026 File No. 333-295727 REQUEST FOR ACCELERATION OF EFFECTIVENESS Ladies and Gentleman: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Traws Pharma, Inc., a Delaware corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-295727) to become effective on Friday, May 15, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Very Truly Yours, Traws Pharma, Inc. By: /s/ Charles Parker Name: Charles Parker Title: Chief Financial Officer